If you have been reading about certificate of analysis and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-26. Numbers and descriptions here follow the published literature rather than marketing material.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is typically supplied as a lyophilized powder for laboratory research. Lyophilization removes water and improves stability during transport and storage. The solid is commonly stored at -20 °C or lower, desiccated, and protected from light. Repeated freeze-thaw cycles and exposure to moisture can degrade peptides, so aliquoting and sealed containers are standard practice in most laboratory settings. These handling measures apply to research-grade material and do not imply clinical suitability.
Purity and identity are usually assessed with reverse-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry. RP-HPLC separates components by hydrophobicity and can estimate peptide purity. Mass spectrometry confirms molecular mass and helps detect truncations or modifications. Some laboratories also use amino acid analysis or nuclear magnetic resonance for structural verification. A certificate of analysis from a supplier may list these results, but independent verification is often recommended for critical work.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
{\displaystyle Q=\left[m_{\text{N}}\left({\ce {^{\mathit {A}}_{\mathit {Z}}X}}\right)-m_{\text{N}}\left({\ce {^{\mathit {A}}_{{\mathit {Z}}+1}X'}}\right)-m_{\text{e}}-m_{{\overline {\nu }}_{\text{e}}}\right]c^{2}}
== Gastrointestinal == Anal cancer Appendix cancer Cholangiocarcinoma Carcinoid tumor, gastrointestinal Colon cancer Duodenal cancer Gallbladder cancer Gastric (stomach) cancer Gastrointestinal carcinoid tumor Gastrointestinal stromal tumor (GIST) Liver cancer Pancreatic cancer, islet cell Rectal cancer Small intestine cancer
== External links == Sugimura T, Nagao M, Wakabayashi K (May 1996). "Carcinogenicity of food mutagens". Environmental Health Perspectives. 104 (Suppl 3): 429–33. doi:10.2307/3432798. JSTOR 3432798. PMC 1469643. PMID 8781358. Louis ED, Zheng W, Jiang W, Bogen KT, Keating GA (June 2007). "Quantification of the neurotoxic beta-carboline harmane in barbecued/grilled meat samples and correlation with level of doneness". Journal of Toxicology and Environmental Health, Part A. 70 (12): 1014–9. Bibcode:2007JTEHA..70.1014L. doi:10.1080/15287390601172015. PMC 4993204. PMID 17497412.
Sources: en.wikipedia.org
== Application as a biochemical tool == One of the main uses of this protein is for removing affinity tags from purified recombinant fusion proteins. The reason for the use of TEV protease as a biochemical tool is its high sequence specificity. This specificity allows for the controlled cleavage of proteins when the preference sequence is inserted into flexible loops. It also makes TEV protease relatively non-toxic in vivo as the recognized sequence scarcely occurs in proteins. Although rational design has had limited success in changing protease specificity, directed evolution has been used to change the preferred residue either before or after the cleavage site. In recent developments, a next-generation TEV protease variant called Numacut has been engineered using a combination of AI-guided rational design, allosteric network analysis, and smart mutagenesis. This variant demonstrates efficient and scarless cleavage at ENLYFQ↓X motifs, where virtually all amino acids (except proline) are tolerated in the P1' position, significantly expanding its biotechnological applicability. However, TEV protease does have limitations as a biochemical tool. It is prone to deactivation by self-cleavage (autolysis), though this can be abolished through a single S219V mutation in the internal cleavage site. The protease expressed alone is also poorly soluble, however several attempts have been made to improve its solubility through directed evolution and computational design.
Despite being formally abolished in the 1960s, slavery in Yemen remains a significant issue exacerbated by ongoing conflict and socio-economic instability. An estimated 85,000 people remaining enslaved as of 2022. The Iran-backed Houthi militias have been accused of reinstating traditional slavery systems. Reports indicate that over 1,800 Yemenis have been forced into servitude by prominent Houthi leaders, with the Houthis dividing society into hierarchical classes of masters and slaves.
2008–09 - Michael "Michi" Mueller - Puma Ocean Racing 2011–12 - David "Dave" Swete - Team Sanya 2014–15 - Sophie Ciszek - Team SCA 2017–18 - Bleddyn Mon - Turn the Tide on Plastic 2023–23 - Will Harris - Team Malizia
organizing international conferences and workshops in mass spectrometry improving mass spectrometry education standardizing terminology in the field aiding in the dissemination of mass spectrometry through publications
Sources: en.wikipedia.org
chemical processing, electricity, batteries and electronic components, construction and architecture, healthcare and pharmaceutics, biomedical research, ultra-pure applications, nuclear waste handling, petrochemical, oil and gas, food, beverage processing, water, wastewater management.
== Z == Zeaxanthin 7,8-dioxygenase - Zfp14 zinc finger protein - Zfp28 zinc finger protein - zinc finger - Zinc finger and scan domain containing 30 - Zinc finger containing ubiquitin peptidase 1 - Zinc finger nfx1-type containing 1 - Zinc finger protein 93 - Zinc finger protein 101 - Zinc finger protein 175 - Zinc finger protein 222 - Zinc finger protein 230 - Zinc finger protein 280b - Zinc finger protein 296 - Zinc finger protein 414 - Zinc finger protein 433 - Zinc finger protein 490 - Zinc finger protein 530 - Zinc finger protein 556 - Zinc finger protein 562 - Zinc finger protein 574 - Zinc finger protein 577 - Zinc finger protein 585b - Zinc finger protein 586 - Zinc finger protein 730 - Zinc finger protein 770 - Zinc finger protein 773 - Zinc finger protein 780a - Zinc finger protein 780b - Zinc finger protein 791 - Zinc finger protein 836 - Zinc finger protein 846
For example, it has been argued that lanthanum and actinium cannot be f-block elements because as individual gas-phase atoms, they have not begun to fill the f-subshells. But the same is true of thorium which is never disputed as an f-block element, and this argument overlooks the problem on the other end: that the f-shells complete filling at ytterbium and nobelium, matching the Sc-Y-Lu-Lr form, and not at lutetium and lawrencium as the Sc-Y-La-Ac form would have it. Not only are such exceptional configurations in the minority, but they have also in any case never been considered as relevant for positioning any other elements on the periodic table: in gaseous atoms, the d-shells complete their filling at copper, palladium, and gold, but it is universally accepted by chemists that these configurations are exceptional and that the d-block really ends in accordance with the Madelung rule at zinc, cadmium, and mercury. The relevant fact for placement is that lanthanum and actinium (like thorium) have valence f orbitals that can become occupied in chemical environments, whereas lutetium and lawrencium do not: their f-shells are in the core, and cannot be used for chemical reactions. Thus the relationship between yttrium and lanthanum is only a secondary relationship between elements with the same number of valence electrons but different kinds of valence orbitals, such as that between chromium and uranium; whereas the relationship between yttrium and lutetium is primary, sharing both valence electron count and valence orbital type.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
The lyophilized powder is generally stored at -20 °C or lower, desiccated, and protected from light. Solutions are often aliquoted to avoid repeated freeze-thaw cycles. Specific stability data may vary by formulation and purity.